23例手部腱鞘巨细胞瘤患者术后功能恢复及复发随访结果分析

doi:10.13481/j.1671-587x.20200526

吉林大学学报(医学版) ›› 2020, Vol. 46 ›› Issue (05): 1061-1064.doi: 10.13481/j.1671-587x.20200526

• 临床医学 • 上一篇

23例手部腱鞘巨细胞瘤患者术后功能恢复及复发随访结果分析

张义群¹, 姜炜博², 苑生³, 于维¹

1. 吉林大学中日联谊医院手外科, 吉林长春 130021;
2. 吉林大学第二医院骨科, 吉林长春 130021;
3. 内蒙古自治区霍林郭勒市人民医院骨科, 内蒙古通辽 029200

收稿日期:2020-03-05 发布日期:2020-10-23
通讯作者: 于维,副主任医师,博士研究生导师(Tel:0431-89876962,E-mail:yuweiwei@jlu.edu.cn) E-mail:yuweiwei@jlu.edu.cn
作者简介:张义群(1989-),男,江苏省徐州市人,主治医师,医学博士,主要从事手部疾病诊断和治疗方面的研究。
基金资助:
吉林省卫健委卫生健康技术创新项目资助课题（2019J032）

Analysis on follow-up results of postoperative function and recurrence of 23 patients with tenosynovial giant cell tumor in hand

ZHANG Yiqun¹, JIANG Weibo², YUAN Sheng³, YU Wei¹

1. Department of Hand Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China;
2. Department of Orthopedics, Second Hospital, Jilin University, Changchun 130022, China;
3. Department of Orthopedics, Peoples'Hospital of Huolinguole City, Inner Mongolia Autonomous Region, Tongliao 029200, China

Received:2020-03-05 Published:2020-10-23

摘要/Abstract

摘要： 目的：探讨手部腱鞘巨细胞瘤（TGCT）的术前诊断、手术治疗、功能锻炼及复发因素，为手部TGCT的诊断和治疗提供理论依据。方法：回顾性分析23例手部TGCT患者的临床资料，比较患者术前彩超诊断与术后病理诊断情况，分析手部X线检查结果，随访患者并行浅表局部彩超检查，嘱患者填写《密歇根大学手概况问卷调查表》（MHQ），同时采用E-link测量患者患侧与健侧握力3次，计算患侧手与健侧手的总主动活动度（TAM），评价患者主观满意度和患手功能恢复情况。结果：23例手部TGCT患者，其中包括男性4例，女性19例，年龄18~68岁，平均年龄（48.5±15.1）岁。左手12例，右手11例；局部结节型TGCT（L-TGCT）21例，弥漫型TGCT（D-TGCT）2例。患者的术前彩超诊断结果与术后病理诊断结果均一致，术前X线检查无骨质损害。随访6~26个月，平均随访时间（16.0±6.5）个月，浅表局部彩超检查见肿物复发1例，复发率4.3%。2例D-TGCT患者患侧握力和TAM值较健侧明显降低，21例L-TGCT患者患侧握力和TAM值与健侧比较无明显差异。MHQ得分，80分以下3例，80分以上20例。结论：彻底切除TGCT可降低复发率，术后积极功能锻炼可取得良好的康复效果。

关键词: 腱鞘巨细胞瘤, 浅表局部彩超, 握力, 总主动活动度, 复发

Abstract: Objective: To explore the preoperative diagnosis, surgical treatment, functional exercise and recurrence factors of tenosynovial giant cell tumor (TGCT) in hand,and to provide the theoretical basis for the diagnosis and treatment of TGCT in hand. Methods: The clinical materials of 23 patients with TGCT in hand were retrospectively analyzed.The preoperative ultrasound diagnosis and postoperative pathology diagnosis of the patients were compared. The X-ray examination results of hands were analyzed. The superficial local ultrasound examination of the patients was followed-up. The patients were asked to fill in the Michigan Hand Outcomes Questionnaire (MHQ), and E-Link was used to measure the grip strength of the affected side and the healthy side of the patients three times, the total active motion(TAM) values of both sides were calculated, and the subjective satisfaction and hand function of the patients were evaluated. Results: There were 23 patients with TGCT in hand, including 4 males and 19 females, aged 18-68 years old, mean (48.5±15.1) years old;among them, 12 cases of left-handed, 11 cases of right-handed; 21 cases of local nodular type TGCT(L-TGCT) and 2 cases of diffuse type TGCT(D-TGCT). The preoperative ultrasound diagnosis result was in accord with the postoperative pathology diagnosis results.There was no bone damage in X-ray examination before operation. The patients were followed up for 6-26 months,mean (16±6.5) months;the results of superficial local ultrasound showed recurrence in 1 case,and the recurrence rate was 4.3%. The grip strength and TAM values of the affected sides in 2 patients with D-TGCT were significantly lower than those of the healthy side; the grip strength and TAM values of 21 patients with L-TGCT had no significant differences compared with the healthy sides.The MHQ scores were less than 80 in 3 cases and more than 80 in 20 cases. Conclusion: Complete resection of TGCT can reduce the recurrence rate, and active functional exercise can achieve good rehabilitation effect.

Key words: tenosynovial giant cell tumor, superficial local ultrasound, grip strength, total active motion, recurrence

中图分类号:

R686.1

张义群, 姜炜博, 苑生, 于维. 23例手部腱鞘巨细胞瘤患者术后功能恢复及复发随访结果分析[J]. 吉林大学学报(医学版), 2020, 46(05): 1061-1064.

ZHANG Yiqun, JIANG Weibo, YUAN Sheng, YU Wei. Analysis on follow-up results of postoperative function and recurrence of 23 patients with tenosynovial giant cell tumor in hand[J]. Journal of Jilin University(Medicine Edition), 2020, 46(05): 1061-1064.

参考文献

[1] 王澍寰,田光磊. 手外科学[M].3版.北京:人民卫生出版社,2011:736.
[2] SANSONE V, LONGHINO V. What's in a name? A call for consistency in the classification of tenosynovial giant cell tumour[J].Knee, 2018,25(6):1322-1323.
[3] GOUIN F, NOAILLES T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)[J]. Orthop Traumatol Surg Res, 2017, 103(1S):S91-S97.
[4] GE Y X,GUO G,YOU Y Q,et al. Magnetic resonance imaging features of fibromas and giant cell tumors of the tendon sheath:differential diagnosis[J]. Eur Radiol,2019,29(7):3441-3449.
[5] 顾玉东,王澍寰,侍德. 手外科手术学[M].2版. 上海:复旦大学出版社,2010:1053-1054.
[6] KOUTSERIMPAS C, KASTANIS G, IOANNIDIS A, et al. Giant cell tumors of the tendon sheath of the hand:an 11-year retrospective study[J]. J BUON:Off J Balkan Union Oncol, 2018, 23(5):1546.
[7] GUPTA K, DEY P, GOLDSMITH R, et al. Comparison of cytologic features of giant-cell tumor and giant-cell tumor of tendon sheath[J]. Diagn Cytopathol, 2010, 30(1):14-18.
[8] ÇEVIK H B, KAYAHAN S, ECEVIZ E, et al. Tenosynovial giant cell tumor in the hand:experience with 173 cases[J]. J Hand Surg Asian Pac Vol, 2020, 25(2):158-163.
[9] RAVI V, WANG W L, LEWIS V O. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis[J]. Curr Opin Oncol, 2011,23(4):361-366.
[10] 计学, 马吉军, 李超. 腕部切割伤继发腱鞘巨细胞瘤一例[J]. 中华手外科杂志, 2011,27(5):262-262.
[11] MONDAL K, MANDAL R, KHAN K, et al. Pitfalls in the cytological diagnosis of tenosynovial giant cell tumor:An illustration of eight discordant cases[J]. Diag Cytopathol, 2018,46(3):250-257.
[12] LYNSKEY S J, PIANTA M J. MRI and thallium features of pigmented villonodular synovitis and giant cell tumours of tendon sheaths:A retrospective single centre study of imaging and literature review[J]. Br J Radiol, 2015, 88(1056):20150528.
[13] MASTBOOM M J L, VERSPOOR F G M, HANFF D F, et al. Severity classification of tenosynovial giant cell tumours on MR imaging[J]. Surg Oncol, 2018, 27(3):544-550.
[14] AGARWAL A, PRAKASH M, GUPTA P, et al. Soft tissue masses of hand:a radio-pathological correlation[J]. Radiol Res Pract, 2015, 2015:752054.
[15] MONAGHAN H, SALTER D M, AL-NAFUSSI A. Giant cell tumour of tendon sheath (localised nodular tenosynovitis):clinicopathological features of 71 cases[J]. J Clin Pathol, 2001, 54(5):404-407.
[16] GIUSTINI N, BERNTHAL N M, BUKATA S V, et al. Tenosynovial giant cell tumor:case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature[J]. Clin Sarcoma Res, 2018, 8:14.
[17] BRAHMI M, VINCENEUX A, CASSIER P A. Current systemic treatment options for tenosynovial giant cell tumor/pigmented villonodular synovitis:targeting the CSF₁/CSF1R axis[J]. Curr Treat Options Oncol, 2016, 17(2):10.
[18] OZBEN H, COSKUN T. Giant cell tumor of tendon sheath in the hand:analysis of risk factors for recurrence in 50 cases[J]. BMC Musculoskelet Disord, 2019, 20(1):457.
[19] WOLFE S W,HOTCHKISS R N,PEDERSON W C,等. 田光磊,蒋协远,陈山林,等译. 格林手外科手术学[M]. 北京:人民军医出版社,2012:2008-2009.
[20] 潘勇卫, 田光磊, 荣国威,等. 手部伴骨破坏的腱鞘巨细胞瘤[J]. 中华手外科杂志, 2004, 20(3):152-154.
[21] ADAMS E L, YODER E M, KASDAN M L. Giant cell tumor of the tendon sheath:experience with 65 cases[J]. Eplasty, 2012, 12:e50.

23例手部腱鞘巨细胞瘤患者术后功能恢复及复发随访结果分析

Analysis on follow-up results of postoperative function and recurrence of 23 patients with tenosynovial giant cell tumor in hand

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 14

Metrics

本文评价

推荐阅读 0

[1]	陈菲, 周小越, 白日兰, 崔久嵬. 新一代肿瘤标志物循环肿瘤细胞的研究进展[J]. 吉林大学学报(医学版), 2020, 46(03): 662-667.
[2]	于鹏跃, 赵凤莲, 张晓华, 赵丽娟, 赵丽艳. 血栓弹力图、平均血小板体积/血小板计数比值和纤维蛋白原水平对复发性流产的预测价值[J]. 吉林大学学报(医学版), 2020, 46(01): 127-131.
[3]	段吉清, 所剑, 孙东辉. 两步翻出直肠法在低位直肠癌经自然腔道取标本手术中的应用(附39例报告)[J]. 吉林大学学报(医学版), 2019, 45(03): 683-687.
[4]	朱效慧, 孟琴, 冯世燕. TP53在不明原因复发性流产患者绒毛组织中的表达及其对人滋养层细胞生长的影响[J]. 吉林大学学报(医学版), 2018, 44(04): 796-800.
[5]	杨大伟, 刘晓宁, 于海驰, 董晓明, 王彬, 张伟, 李颖智. 自体腓骨长肌腱前1/2双束解剖重建内侧髌股韧带联合外侧支持带松解治疗复发性髌骨脱位12例报告及文献复习[J]. 吉林大学学报(医学版), 2017, 43(06): 1248-1252.
[6]	王溪, 韩今华, 李云峰, 杨艳明. 热疗联合¹²⁵I粒子治疗复发性直肠癌的近期疗效评价[J]. 吉林大学学报(医学版), 2017, 43(05): 963-966.
[7]	和秀魁, 陶莉莉, 袁晓兰, 齐一鸣, 罗喜平, 潘碧琦. 可溶性Tim-3对原因不明性复发性流产患者Th1/Th2分化的免疫调节作用及其机制[J]. 吉林大学学报(医学版), 2016, 42(06): 1163-1167.
[8]	张矛，苏清秀，杨金磊，金海国，董莹，吴丹，王福香. 局部复发鼻咽癌患者再程放疗技术的剂量学参数比较[J]. 吉林大学学报(医学版), 2014, 40(05): 1085-1089.
[9]	李恩喜，尹威民，王旭，马克威. 吉西他滨联合顺铂方案在非小细胞肺癌术后辅助化疗中的疗效及影响因素分析 [J]. 吉林大学学报(医学版), 2013, 39(1): 122-127.
[10]	钟淑霞\|李珊山\|郑华\|刘鹤松\|温泉\|王圆圆. 强脉冲光联合药物治疗面部皮炎的临床疗效评价[J]. J4, 2011, 37(3): 545-547.
[11]	张浩然，赵劼，孙辉，温强，赵国庆，马庆杰. ⁹⁹Tcm-MIBI影像与分化型甲状腺癌手术¹³¹I清甲后复发的系[J]. J4, 2008, 34(6): 1071-1074.
[12]	李丹丹，赵劼，孙辉，温强，高识，马庆杰，赵国庆. 分化型甲状腺癌手术联合¹³¹I清甲治疗后复发与乏氧诱导因子-lα表达的关系[J]. J4, 2008, 34(5): 867-870.
[13]	王斌，宋燕. 骨桥蛋白在结肠癌组织中的表达及血清水平检测[J]. J4, 2007, 33(2): 324-326.
[14]	贾明库，闫秀欣，陈云波，金炎. 原发性肝癌根治性切除术后的综合治疗[J]. J4, 2004, 30(1): 141-142.